Categories: BrainCancerNews

Carson Leslie Foundation Expands Collaboration with the Children’s Brain Tumor Network

PHILADELPHIA, Feb. 27, 2025 /PRNewswire/ — The Children’s Brain Tumor Network (CBTN) announces the addition of the Carson Leslie Foundation to its Executive Council. The foundation has supported multiple CBTN projects over the past four years, most recently donating $100,000 to fuel the CBTN medulloblastoma liquid biopsy project, which promises to deliver a less invasive way to track treatment progress for this aggressive disease.

By working together, we can make a difference in the lives of children across a wide range of brain tumor diagnoses.

“We are thrilled to welcome the Carson Leslie Foundation to our Executive Council,” said Jena Lilly, CBTN Executive Director. “Their expertise in research and advocacy will be invaluable as we work to improve the long-term prospects of children diagnosed with brain tumors.”

The Carson Leslie Foundation was founded in memory of Carson Leslie, a young man who lost his battle with medulloblastoma in 2010. The foundation is committed to funding research that will lead to better treatments and, ultimately, a cure for this devastating disease.

“The Carson Leslie Foundation’s participation in the Executive Council is rooted in our deep belief that pediatric brain tumor organizations MUST work together to progress in each of our respective areas of clinical focus,” said Ripley Martin, Board Member of the Carson Leslie Foundation. “We believe that by working together, we can make a real difference in the lives of children across a wide range of brain tumor diagnoses.”

Learn more about the Carson Leslie Foundation and the CBTN Executive Council here to discover why this partnership is a significant step forward in the fight against pediatric brain cancer.

About Children’s Brain Tumor Network (CBTN)

CBTN is a collaborative research enterprise created to ensure that no child suffers or dies from a brain tumor. The 35 international member institutions comprising CBTN have enrolled more than 7,000 study participants and more than 70,000 biospecimen samples to create the world’s most comprehensive repository of childhood brain tumors. The CBTN suite of cloud-based informatics and analytics platforms enables researchers and clinicians to collaborate in real-time on behalf of children diagnosed with brain tumors. To learn more, visit cbtn.org.

Whitney Rife
rifew@chop.edu
609-947-6809

View original content to download multimedia:https://www.prnewswire.com/news-releases/carson-leslie-foundation-expands-collaboration-with-the-childrens-brain-tumor-network-302386160.html

SOURCE Children’s Brain Tumor Network

Staff

Recent Posts

TempraMed Closes C$2.5 Million Fully Subscribed Private Placement

Vancouver, British Columbia--(Newsfile Corp. - January 12, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…

2 hours ago

TruuCONNECT NJ Statewide Digital Hub Empowers Users to Find Verified, Local Community Resources and Support – Anonymously and in Real Time

MOUNT LAUREL, N.J., Jan. 12, 2026 /PRNewswire/ -- Born out of a partnership between the…

2 hours ago

Nuvo Unveils Large-Scale AI-Ready Pregnancy Dataset Built on Real-World Maternal and Fetal Physiology

Unique longitudinal dataset combining native fetal and maternal ECG with phonocardiography supports deeper insights into…

2 hours ago

Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research

FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision…

2 hours ago

RxAnte Announces Strategic Growth Investment from Primus Capital

PORTLAND, Maine, Jan. 12, 2026 /PRNewswire/ -- RxAnte, the leading provider of analytics, software, and…

2 hours ago

PulseAI Secures Seed Funding to Advance AI-Driven ECG Diagnostics

BELFAST, Northern Ireland  , Jan. 12, 2026 /PRNewswire/ -- PulseAI, a rapidly emerging leader in…

2 hours ago